Aseptic Formulation and Filling Using Isolator Technology

Folks,Jeff;

Aseptic Formulation and Filling Using Isolator Technology

August 1, 2003

By Jeff L. Folks

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-08-01-2003

Volume 2003 Supplement

Issue 4

Isolator technology can be used in clinical product formulation and filling facilities to ensure environmental control and reduce contamination risk in aseptic processing.

External Link - article-67145.pdf

Articles in this issue

Survey Finds Outsourcing Practice Continuing to Mature

Trends in Impurity Analysis: Determination of Extractables, Leachables, Residual Solvents, and Unknowns by Mass Spectrometry

Aseptic Formulation and Filling Using Isolator Technology

Related Content

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney

June 27th 2025

Article

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney

June 25th 2025

Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.